AKT1 and early-onset autosomal dominant Alzheimer disease: Therapeutic use of PI3K/Akt inhibitors has been applied in patients with differenttypes of cancer,29 whereas GSK3β protein inhibitors are used in the treatment ofneurodegenerative diseases such as Alzheimer’s disease.30